Abeona Therapeutics Inc.
ABEO- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000318306
In the last 90 days, Abeona Therapeutics Inc. insiders filed 0 open-market purchases and 7 sales; 126 institutions reported holding it in 13F filings for Q2 2026, worth $243.3M in total; no superinvestor holds it.
13F holders, Q2 2025
Institutional positions in Abeona Therapeutics Inc. as of Jun 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 95
- +24 vs. Q1 2025
- Shares held
- 34.9M
- +5.23M (+17.6%) vs. Q1 2025
- Total value
- $198.2M
- +$57.0M (+40.4%) vs. Q1 2025
- New holders
- 42
- 31 more added
- Sold out
- 18
- 12 more reduced
Compare with Q1 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ABEO on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 126 | $243.3M |
| Q1 2026 | 108 | $177.1M |
| Q4 2025 | 104 | $205.2M |
| Q3 2025 | 100 | $187.9M |
| Q2 2025 | 95 | $198.2M |
| Q1 2025 | 71 | $141.2M |
| Q4 2024 | 65 | $170.4M |
| Q3 2024 | 55 | $181.7M |
| Q2 2024 | 48 | $127.8M |
| Q1 2024 | 56 | $104.7M |
| Q4 2023 | 48 | $70.8M |
| Q3 2023 | 40 | $52.5M |
| Q2 2023 | 37 | $37.9M |
| Q1 2023 | 33 | $21.2M |
| Q4 2022 | 41 | $28.5M |
| Q3 2022 | 25 | $3.62M |
| Q2 2022 | 44 | $4.51M |
| Q1 2022 | 56 | $10.3M |
| Q4 2021 | 53 | $13.7M |
| Q3 2021 | 60 | $28.3M |
| Q2 2021 | 73 | $43.4M |
| Q1 2021 | 78 | $58.4M |
Institutions, Q2 2025
Shares, value and share of portfolio for each institution holding Abeona Therapeutics Inc.; share changes are against Q1 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Connective Capital Management, LLC | 0 | $0 | 0.00% | −74,913−100.0% | Sold out |
| Balyasny Asset Management LLC | 0 | $0 | 0.00% | −73,849−100.0% | Sold out |
| Omers Administration Corp | 0 | $0 | 0.00% | −72,200−100.0% | Sold out |
| Schonfeld Strategic Advisors LLC | 0 | $0 | 0.00% | −65,011−100.0% | Sold out |
| Gsa Capital Partners LLP | 0 | $0 | 0.00% | −63,835−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −32,044−100.0% | Sold out |
| LMR Partners LLP | 0 | $0 | 0.00% | −27,120−100.0% | Sold out |
| Quantessence Capital LLC | 0 | $0 | 0.00% | −26,087−100.0% | Sold out |
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −24,409−100.0% | Sold out |
| Engineers Gate Manager LP | 0 | $0 | 0.00% | −20,501−100.0% | Sold out |
| Jefferies Financial Group Inc. | 0 | $0 | 0.00% | −18,000−100.0% | Sold out |
| Cannon Global Investment Management, LLC | 0 | $0 | 0.00% | −14,000−100.0% | Sold out |
| Avion Wealth | 0 | $0 | 0.00% | −85−100.0% | Sold out |